According to a recent filing with the Securities and Exchange Commission, Julian and Felix Bakers‘ Baker Bros. Advisors are bullish on Anacor Pharmaceuticals Inc (NASDAQ:ANAC). The filing showed that Baker Bros. owns a passive stake in Anacor, which contains some 4.87 million shares of the company, which represent 11% of the outstanding common stock. This compares with the 4.14 million-share position that Baker Bros. revelead in its last 13F filing (for the end of the third quarter of 2015).
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|Baker Bros. Advisors||4,871,046||0||4,871,046||0||4,871,046||11.0%|
|Baker Bros. Advisors (GP)||4,871,046||0||4,871,046||0||4,871,046||11.0%|
|Felix J. Baker||4,871,046||0||4,871,046||0||4,871,046||11.0%|
|Julian C. Baker||4,871,046||0||4,871,046||0||4,871,046||11.0%|
Page 1 of 10 SEC Filing
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
the Securities Exchange Act of 1934
|Anacor Pharmaceuticals, Inc.|
|(Name of Issuer)|
|Common Stock, par value $0.001 per share|
|(Title of Class of Securities)|
|January 15, 2016|
|(Date of Event which Requires Filing of this Statement)|
the appropriate box to designate the rule pursuant to which this Schedule is filed:
of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover
required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of
the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act,
but shall be subject to all other provisions of the Act (however, see the Notes).